Amanta Healthcare Ltd. IPO
₹120 - ₹120
119
N/A
| Open Date: | 01-Sep-2025 |
| Close Date: | 03-Sep-2025 |
| Allotment Date: | 04-Sep-2025 |
| Listing Date: | N/A |
| Listing Price: | N/A |
| Face Value: | ₹₹10 per share Per Equity Share |
| Issue Price: | ₹120.00 to 126.00 Per Equity Share |
| Issue Size: | 1,00,00,000 shares (aggregating up to ₹126.00 Cr) |
| Market Lot (Min Amount): | 119 Shares |
| QIB Shares Offered | Not more than 50.00% of the Net Issue |
| Retail Shares Offered | Not less than 35.00% of the Net Issue |
| NII Shares Offered | Not less than 15.00% of the Net Issue |
| Assets | 381.76 |
| Net Worth | 96.39 |
| Revenue | |
| Profit After Tax | 10.50 |
| 1. The promoters of the Company are Bhavesh Patel |
| 2. Vishal Patel |
| 3. Jayshreeben Patel |
| 4. Jitendra Kumar Patel and Milcent Appliances Private Limited. |
- Incorporated in December 1994, Amanta Healthcare Limited is a pharmaceutical company that specializes in the development, manufacturing, and marketing of a diverse array of sterile liquid products, specifically parenteral products, which are packaged in plastic containers utilizing Aseptic Blow-Fill-Seal (“ABFS”) and Injection Stretch Blow Moulding (“ISBM”) technologies. The company is also a manufacturer of medical devices.
- The company manufactures fluid therapy formulations, including IV fluids, diluents, ophthalmic solutions, and respiratory care products. It also offers irrigation solutions, first-aid products, and eye lubricants in the medical device segment.
- The company manufactures over 45 generic products, marketing them under their brands in India through 320 distributors and stockists.
- The company sells products in Africa, Latin America, the UK, and beyond. Its products are registered in 19 countries and comply with various regulations. In Fiscal 2025, the company exported branded products to 21 countries.
- Experienced management team supported by a large, diverse and skilled workforce.
No financial information whatsoever published anywhere, within this application, should be considered as an advise to buy or sell securities or invest in IPOs, or as guide to do so in any way whatsoever. All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions.
Also we are not a SEBi registered analyst comapny. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on information published on this application. Above information is based on information available as on date coupled with market perceptions.
If you are agree with app tems and condition to use the app.
Thank you.